Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P22830: Variant p.Phe417Ser

Ferrochelatase, mitochondrial
Gene: FECH
Feedback?
Variant information Variant position: help 417 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Phenylalanine (F) to Serine (S) at position 417 (F417S, p.Phe417Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In EPP1; reduced activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 417 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 423 The length of the canonical sequence.
Location on the sequence: help KQLTLSCPLCVNPVCRETKS F FTSQQL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         KQLTLSCPLCV--NPVCRETKSFFTSQQL-

Chimpanzee                    KQLTLSCPLCV--NPVCRETKSFFTSQ

Mouse                         TQLSLNCPLCV--NPVCRKTKSFFTSQ

Bovine                        TQLTLSCPLCV--NPTCRETKSFFTSQ

Chicken                       KQLTLCCPLCV--NPVCRETKAFFTNQ

Xenopus laevis                KQLSLRCPMCV--NPVCGEAKSFFTKQ

Drosophila                    PKFLMRCPMCS--NPKCRESKSWYRQL

Slime mold                    NQYHLKCPGCKDDSTFCRTISNPIQAL

Baker's yeast                 NQLPLDFALGKSNDPV-KDLSLVFGNH

Fission yeast                 RQFTQRCPGCT--SESCAERINFFQDF
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 55 – 423 Ferrochelatase, mitochondrial
Binding site 403 – 403
Binding site 406 – 406
Binding site 411 – 411
Modified residue 415 – 415 N6-acetyllysine; alternate
Modified residue 415 – 415 N6-succinyllysine; alternate
Mutagenesis 403 – 403 C -> DH. Loss of activity.
Mutagenesis 406 – 406 C -> DHS. Loss of activity.
Mutagenesis 411 – 411 C -> HS. Loss of activity.
Mutagenesis 417 – 417 F -> L. Decreased activity.
Mutagenesis 417 – 417 F -> YW. Greatly reduced activity.
Helix 410 – 419



Literature citations
A molecular defect in human protoporphyria.
Brenner D.A.; Didier J.M.; Frasier F.; Christensen S.R.; Evans G.A.; Dailey H.A.;
Am. J. Hum. Genet. 50:1203-1210(1992)
Cited for: VARIANT EPP1 SER-417;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.